Johns Hopkins Medicine: Novel Peptide Therapy Shows Promise for Treating Obesity, Diabetes and Aging
November 22, 2023
November 22, 2023
BALTIMORE, Maryland, Nov. 22 (TNSres) -- Johns Hopkins Medicine issued the following news release:
A recent study from researchers at the Johns Hopkins University School of Medicine -- published Oct. 26 in Cell Chemical Biology -- indicates that newly designed AMPK-targeting peptides Pa496h and Pa496m may improve mitochondrial dynamics and high blood glucose levels in people with diabetes, obesity and age-related metabolic disorders based on findings from mice and human cells.
. . .
A recent study from researchers at the Johns Hopkins University School of Medicine -- published Oct. 26 in Cell Chemical Biology -- indicates that newly designed AMPK-targeting peptides Pa496h and Pa496m may improve mitochondrial dynamics and high blood glucose levels in people with diabetes, obesity and age-related metabolic disorders based on findings from mice and human cells.
. . .